An intrauterine progesterone contraceptive system (52 mg) used in pre- and peri-menopausal patients with endometrial hyperplasia
- 1 January 1982
- Vol. 4 (1), 73-79
- https://doi.org/10.1016/0378-5122(82)90022-6
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- A prospective study of plasma prolactin levels in women using the progesterone releasing intrauterine device (P-IUD)Contraception, 1979
- Studies of Carbohydrate and Lipid Metabolism in Women Using the Progesterone-T Intrauterine Device for Six Months: Blood Glucose, Insulin, Cholesterol, and Triglyceride LevelsFertility and Sterility, 1978
- Effects of the progestasert® on the menstrual pattern, ovarian steroids and endometriumContraception, 1977
- Effect of progesterone on human endometrial carcinoma in different experimental systemsActa Obstetricia et Gynecologica Scandinavica, 1972
- ENDOMETRIAL CARCINOMA AND SYNTHETIC PROGESTOGENS RESULTS OF INTRAUTERINE TREATMENTBJOG: An International Journal of Obstetrics and Gynaecology, 1970
- Survival and Hormonal Responsiveness of Endometrial Carcinoma in Organ CultureActa Obstetricia et Gynecologica Scandinavica, 1970
- THE EFFECT OF HORMONES ON ENDOMETRIAL CARCINOMA IN ORGAN CULTUREBJOG: An International Journal of Obstetrics and Gynaecology, 1968
- Effect of a Progestational Agent on Endometrial Hyperplasia and Endometrial CancerObstetrics & Gynecology, 1964
- Classification of Endometrial Response to Synthetic Progestogen-Estrogen CompoundsFertility and Sterility, 1964
- CONTEMPORARY THERAPY OF THE MENOPAUSAL SYNDROMEJAMA, 1959